Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Variation in coagulation factor activity levels cause discrepancies between activated partial thromboplastin time and anti-Xa activity for heparin monitoring: a retrospective observational study.
Saito T, Hayakawa M, Kumano O, Honma Y, Murashita M, Kato J, Fukui S, Takahashi M, Takahashi Y, Tsuchida T, Mizugaki A, Takauji S, Hayamizu M, Yoshida T, Katabami K, Wada T, Maekawa K. Saito T, et al. Among authors: kumano o. J Intensive Care. 2023 Nov 16;11(1):54. doi: 10.1186/s40560-023-00701-3. J Intensive Care. 2023. PMID: 37974289 Free PMC article.
Evaluation of newly-developed modified diluted prothrombin time reagent in non-valvular atrial fibrillation patients with direct oral anticoagulants: A comparative study with conventional reagents.
Kumano O, Suzuki S, Yamazaki M, An Y, Yasaka M, Ieko M; Japanese study group for the assessment of direct oral anticoagulants. Kumano O, et al. Int J Lab Hematol. 2023 Feb;45(1):119-125. doi: 10.1111/ijlh.13971. Epub 2022 Sep 16. Int J Lab Hematol. 2023. PMID: 36114152
Newly developed modified diluted prothrombin time reagent: A multi-centre validation in patients with non-valvular atrial fibrillation under direct oral anticoagulant therapy.
Kumano O, Suzuki S, Yamazaki M, An Y, Yasaka M, Ieko M; Japanese study group for the assessment of direct oral anticoagulants. Kumano O, et al. Thromb Res. 2022 Feb;210:87-90. doi: 10.1016/j.thromres.2021.12.028. Epub 2022 Jan 4. Thromb Res. 2022. PMID: 35033861 No abstract available.
39 results